CEO Sean Duffy Sells Over $4.2M in Omada Health Stock
summarizeZusammenfassung
The Chief Executive Officer of Omada Health, Sean P. Duffy, executed a significant sale of company stock totaling over $4.2 million. This transaction involved exercising options at a low strike price and immediately selling the acquired shares in the open market. While the options were set to expire imminently, a sale of this magnitude by a key executive can be interpreted as a move to diversify personal holdings or a signal of reduced confidence. Investors should monitor future insider activity and company performance closely.
check_boxSchlusselereignisse
-
CEO Sells Significant Stake
Sean P. Duffy, CEO and Director, sold common stock valued at approximately $4.25 million in open market transactions on January 12-13, 2026.
-
Option Exercise Preceded Sale
The sales followed the exercise of options to acquire 271,275 shares at a price of $2.55 per share, which were then sold in the open market between $15.35 and $15.99.
-
Reduction in Direct Holdings
Post-transaction, the CEO's direct holdings decreased to 357,123 shares.
auto_awesomeAnalyse
The Chief Executive Officer of Omada Health, Sean P. Duffy, executed a significant sale of company stock totaling over $4.2 million. This transaction involved exercising options at a low strike price and immediately selling the acquired shares in the open market. While the options were set to expire imminently, a sale of this magnitude by a key executive can be interpreted as a move to diversify personal holdings or a signal of reduced confidence. Investors should monitor future insider activity and company performance closely.
Zum Zeitpunkt dieser Einreichung wurde OMDA bei 15,45 $ gehandelt an der NASDAQ im Sektor Industrial Applications And Services, bei einer Marktkapitalisierung von rund 897,6 Mio. $. Die 52-Wochen-Handelsspanne lag zwischen 14,14 $ und 28,40 $. Diese Einreichung wurde mit negativer Marktstimmung und einem Wichtigkeitsscore von 9 von 10 bewertet.